Lisinopril Tablets USP — Class II drug recall D-1413-2020
Terminated recall by Lupin Pharmaceuticals Inc., reported 2020-08-05, distributed nationwide. Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril
| Recall number | D-1413-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Lupin Pharmaceuticals Inc., Baltimore, MD, United States |
| Recall initiated | 2020-07-17 |
| Classified | 2020-07-28 |
| Reported by FDA | 2020-08-05 |
| Terminated | 2021-08-26 |
| Distributed | Nationwide (US) |
| Quantity | 11,688 bottles |
| NDC | 68001-0332, 68001-0332-00, 68001-0332-03, 68001-0333, 68001-0333-00, 68001-0333-08, 68001-0334, 68001-0334-00, 68001-0334-08, 68001-0335, 68001-0335-00, 68001-0335-08, 68001-0336, 68001-0336-00, 68001-0337, 68001-0337-00, 68001-0337-08, 68001-0486, 68001-0486-00, 68001-0486-08 |
| Lot numbers | Q000232 |
| Expiration dates | 2022-01 |
Product
Lisinopril Tablets USP, 10 mg, 1000 count bottles, Manufactured by: Lupin Limited, Nagpur INDIA, For BluePoint Laboratories NDC 68001-334-08
Reason for recall
Presence of Foreign Tablets/Capsules: Lisinopril Tablets USP, 20mg found in a 1000 count bottle of Lisinopril Tablets USP, 10mg
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1413-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.